Price when posted : NSE: Rs. 1582.45
it is an establishment inspection report that is issued by us fda after satisfactory reply from the company against the issued observation. this is po see more...
Price when posted : NSE: Rs. 1590.85
Price when posted : NSE: Rs. 1581.00
The US Food and Drug Administration (US FDA) has issued an establishment inspection report for the companys Aurangabad manufacturing facility. The US see more... 2 replies
Price when posted : NSE: Rs. 1580.05
The inspection was conductedfrom March 6 to March 15, 2024. The U.S. FDA has determined that the inspection classification ofthe facility is Voluntary see more...
Price when posted : NSE: Rs. 1580.05
Price when posted : NSE: Rs. 1580.05
Price when posted : NSE: Rs. 1599.00
the stock has given a good breakdown below its immediate support mark of rs 1,553 on its daily charts. with the rsi (14) near 37.10 and volumes in fri see more...
Price when posted : NSE: Rs. 1599.30
Price when posted : NSE: Rs. 1599.90
Price when posted : NSE: Rs. 1600.00
Lupin launches generic drug in US market The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Dr see more...
MARKET VIEW
OUTLOOK
SECTORS
STRATEGY
VIEW
PERSONAL FINANCE
INSURANCE
INVEST
MUTUAL FUND
GENERAL